JP2021503610A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2021503610A5 JP2021503610A5 JP2020545038A JP2020545038A JP2021503610A5 JP 2021503610 A5 JP2021503610 A5 JP 2021503610A5 JP 2020545038 A JP2020545038 A JP 2020545038A JP 2020545038 A JP2020545038 A JP 2020545038A JP 2021503610 A5 JP2021503610 A5 JP 2021503610A5
- Authority
- JP
- Japan
- Prior art keywords
- proteins
- protein
- fragments
- biomarkers
- sample
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024001282A JP2024038290A (ja) | 2017-11-16 | 2024-01-09 | 神経損傷および／または疾患のタンパク質バイオマーカー指標及びその使用の方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762587272P | 2017-11-16 | 2017-11-16 | |
| US62/587,272 | 2017-11-16 | ||
| PCT/US2018/061372 WO2019099732A1 (en) | 2017-11-16 | 2018-11-15 | Protein biomarker indicators of neurological injury and/or disease and methods of use thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024001282A Division JP2024038290A (ja) | 2017-11-16 | 2024-01-09 | 神経損傷および／または疾患のタンパク質バイオマーカー指標及びその使用の方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021503610A JP2021503610A (ja) | 2021-02-12 |
| JP2021503610A5 true JP2021503610A5 (https=) | 2022-09-28 |
Family
ID=66538796
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020545038A Withdrawn JP2021503610A (ja) | 2017-11-16 | 2018-11-15 | 神経損傷および／または疾患のタンパク質バイオマーカー指標及びその使用の方法 |
| JP2024001282A Pending JP2024038290A (ja) | 2017-11-16 | 2024-01-09 | 神経損傷および／または疾患のタンパク質バイオマーカー指標及びその使用の方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024001282A Pending JP2024038290A (ja) | 2017-11-16 | 2024-01-09 | 神経損傷および／または疾患のタンパク質バイオマーカー指標及びその使用の方法 |
Country Status (4)
| Country | Link |
|---|---|
| US (2) | US11988676B2 (https=) |
| EP (1) | EP3710836A4 (https=) |
| JP (2) | JP2021503610A (https=) |
| WO (1) | WO2019099732A1 (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3688020A4 (en) | 2017-09-25 | 2021-07-14 | University of Florida Research Foundation, Incorporated | IMMUNOASSAYS FOR DETECTION OF RAN PROTEINS |
| EP3779448A1 (en) * | 2019-08-12 | 2021-02-17 | Baden-Württemberg Stiftung gGmbH | Novel diagnostic marker for creutzfeldt-jakob disease and alzheimer's disease |
| US20220326258A1 (en) * | 2019-09-13 | 2022-10-13 | Northwestern University | Biomarkers for amyotrophic lateral sclerosis (als) and motor neuron diseases |
| WO2021055880A1 (en) * | 2019-09-20 | 2021-03-25 | University Of Florida Researchfoundation, Incorporated | Detection of antibodies against ran proteins from serum and tissue lysates |
| EP4111197A1 (en) * | 2020-02-25 | 2023-01-04 | Markus Otto | Diagnosing a disease associated with synaptic degeneration using an elisa for determining a beta-synuclein concentration in csf |
| JPWO2022176958A1 (https=) * | 2021-02-17 | 2022-08-25 | ||
| WO2023092157A1 (en) * | 2021-11-22 | 2023-05-25 | Brainbox Solutions, Inc. | Biomarker testing for chronic persistent injury following brain trauma |
| JP7670286B2 (ja) * | 2022-06-21 | 2025-04-30 | ａｉｗｅｌｌ株式会社 | 情報処理システム、特定システムおよびプログラム |
| WO2024050133A1 (en) * | 2022-09-01 | 2024-03-07 | GATC Health Corp | Digital twin for diagnostic and therapeutic use |
| WO2025099851A1 (ja) * | 2023-11-08 | 2025-05-15 | ａｉｗｅｌｌ株式会社 | 情報処理システム、特定システムおよびプログラム |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE60233949D1 (de) * | 2001-08-20 | 2009-11-19 | Biosite Inc | Diagnostische marker für schlaganfall und hirntrauma sowie verfahren zur verwendung davon |
| CA2804763C (en) * | 2010-07-14 | 2023-01-03 | The Regents Of The University Of California | Biomarkers for diagnosis of transient ischemic attacks |
| CA2818887A1 (en) * | 2010-11-26 | 2012-05-31 | Immunexpress Pty Ltd | Diagnostic and/or screening agents and uses therefor |
| EP2607900A1 (de) * | 2011-12-22 | 2013-06-26 | Protagen AG | Markersequenzen für Brustkrebs und deren Verwendung |
| US10809271B2 (en) * | 2015-03-27 | 2020-10-20 | The Translational Genomics Research Institute | Biomarkers and methods of diagnosing and prognosing mild traumatic brain injuries |
| CN107864671A (zh) * | 2015-05-05 | 2018-03-30 | 加利福尼亚大学董事会 | 星形细胞创伤节和神经创伤生物标志物 |
| JP2018524575A (ja) | 2015-06-18 | 2018-08-30 | シーダーズ−サイナイ メディカル センター | 疾患の診断におけるシトルリン化の役割 |
| US20170145506A1 (en) * | 2015-11-24 | 2017-05-25 | University Of Rochester | Signature of Longitudinal Gene Expression Changes to Diagnose Brain Injury |
-
2018
- 2018-11-15 WO PCT/US2018/061372 patent/WO2019099732A1/en not_active Ceased
- 2018-11-15 EP EP18879163.6A patent/EP3710836A4/en active Pending
- 2018-11-15 US US16/763,794 patent/US11988676B2/en active Active
- 2018-11-15 JP JP2020545038A patent/JP2021503610A/ja not_active Withdrawn
-
2024
- 2024-01-09 JP JP2024001282A patent/JP2024038290A/ja active Pending
- 2024-04-25 US US18/645,977 patent/US20250044303A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021503610A5 (https=) | ||
| TW201606307A (zh) | 阿茲海默症及其他神經退化性疾病之生物標記及診斷方法 | |
| JP2013092538A (ja) | 脳損傷関連障害の診断法 | |
| Solini et al. | P2X7 receptor/NLRP3 inflammasome complex and α‐synuclein in peripheral blood mononuclear cells: a prospective study in neo‐diagnosed, treatment‐naïve Parkinson’s disease | |
| US9977036B2 (en) | Diagnostic markers for multiple sclerosis | |
| Stampanoni Bassi et al. | Platelet-derived growth factor predicts prolonged relapse-free period in multiple sclerosis | |
| Al-Temaimi et al. | Remyelination modulators in multiple sclerosis patients | |
| Xi et al. | TXNIP regulates NLRP3 inflammasome-induced pyroptosis related to aging via cAMP/PKA and PI3K/Akt signaling pathways | |
| Zhang et al. | Altered cerebrospinal fluid index of prealbumin, fibrinogen, and haptoglobin in patients with Guillain–Barré syndrome and chronic inflammatory demyelinating polyneuropathy | |
| ES2400255T3 (es) | Procedimiento in vitro para la diagnosis y la diagnosis precoz de enfermedades neurodegenerativas | |
| He et al. | Huwe1 interacts with Gadd45b under oxygen-glucose deprivation and reperfusion injury in primary Rat cortical neuronal cells | |
| ES2353722T3 (es) | Procedimiento de diagnosis in vitro por examen del líquido cefalorraquídeo para el diagnóstico de enfermedades de demencia y enfermedades neuroinflamatorias. | |
| KR20220112204A (ko) | 뇌의 레닌-안지오텐신 시스템 인자를 이용한 알츠하이머병의 진단 방법 | |
| US20250271452A1 (en) | Assays and methods of use of those assays in the care and diagnosis of stroke patients | |
| Humble et al. | Aquaporin-4 positive extracellular vesicles and cytokines in cerebrospinal fluid in schizophrenia and obsessive-compulsive disorder, and associations with peripheral cytokines | |
| Sasmita et al. | Correlation between serum S100β protein level with neurological deficit in patients with acute intracerebral hemorrhage | |
| Golubev et al. | Molecular markers of ischemic stroke | |
| Lance et al. | Proteomic discovery in sickle cell disease: Elevated neurogranin levels in children with sickle cell disease | |
| Mashayekhi et al. | Quantitative analysis of cerebrospinal fluid brain derived neurotrophic factor in the patients with multiple sclerosis | |
| US20240302365A1 (en) | Method for diagnosing chronic urticaria | |
| CN114137214B (zh) | 用于预测应激后精神心理症状发生的免疫检测试剂盒及应用 | |
| US20030119074A1 (en) | Diagnosis and treatment of dementia utilizing thrombospondin | |
| CN115698721A (zh) | 用于卒中的评估的ret（转染重排） | |
| RU2840435C1 (ru) | Способ оценки тяжести анти-nmda-рецепторного энцефалита с выраженной психопатологической симптоматикой | |
| US20140171413A1 (en) | Compositions and methods for diagnosis of schizophrenia |